Cite
HARVARD Citation
Ghosh, S. et al. (n.d.). P434 Upadacitinib improved fatigue and health-related quality of life in patients with moderately to severely active Crohn's disease: Results from induction and maintenance phase 3 trials. Journal of Crohn's and colitis. pp. i560-i562. [Online].